Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Public ClinicalTrials.gov record NCT05429632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT
Study identification
- NCT ID
- NCT05429632
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Priothera SAS
- Industry
- Enrollment
- 366 participants
Conditions and interventions
Conditions
Interventions
- mocravimod Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2022
- Primary completion
- Apr 30, 2027
- Completion
- Oct 31, 2029
- Last update posted
- Apr 23, 2026
2022 – 2029
United States locations
- U.S. sites
- 21
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Hospital (UAB Hospital) | Birmingham | Alabama | 35233-1932 | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234-2165 | Withdrawn |
| City of Hope Comprehensive Cancer Center - Duarte | Duarte | California | 91010 | Recruiting |
| University of California Los Angeles (UCLA) - David Geffen School of Medicine | Los Angeles | California | 90095 | Recruiting |
| UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center | Aurora | Colorado | 80045 | Withdrawn |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Active, not recruiting |
| Emory University - Winship Cancer Institute (WCI) | Atlanta | Georgia | 30322-1013 | Recruiting |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | Recruiting |
| University of Kansas Cancer Center | Westwood | Kansas | 66103 | Recruiting |
| Ochsner Medical Center (OMC) - New Orleans | New Orleans | Louisiana | 70121 | Withdrawn |
| University of Maryland Medical Center (UMMC) | Baltimore | Maryland | 21201-1544 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Withdrawn |
| Henry Ford Cancer Institute | Detroit | Michigan | 48202-2610 | Recruiting |
| Spectrum Health Medical Group (SHMG) - Blood & Marrow Transplant - Adult (BMT) | Grand Rapids | Michigan | 49503 | Recruiting |
| University of Rochester Medical Center (URMC) | Rochester | New York | 14642 | Recruiting |
| Stony Brook University (SBU) - Cancer Center | Stony Brook | New York | 11794-0001 | Recruiting |
| University of Cincinnati Medical Center (University Hospital) | Cincinnati | Ohio | 45267 | Recruiting |
| The Ohio State University Comprehensive Cancer Center (OSUCCC) | Cleveland | Ohio | 44106-1716 | Recruiting |
| Oregon Health & Science University (OHSU) - Knight Cancer Institute | Portland | Oregon | 97239-3098 | Recruiting |
| University of Pennsylvania - Abramson Cancer Center | Philadelphia | Pennsylvania | 19104-4206 | Suspended |
| Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05429632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05429632 live on ClinicalTrials.gov.